Tag: gastroesophageal junction cancer

New Phase III Data Shows Survival Benefit in Advanced Gastric Cancer

AstraZeneca reports positive Phase III CLARITY-Gastric01 results showing sonesitatug vedotin significantly improves…

ME Desk

Amgen’s Cancer Therapy Meets Key Goal in Phase 3 Gastric Cancer Study

Amgen announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6)…

ME Desk